Healthcare Stocks To Add to Your Watchlist – March 23rd

Merck & Co., Inc., Alphabet, UnitedHealth Group, Amgen, Johnson & Johnson, Salesforce, and Oracle are the seven Healthcare stocks to watch today, according to MarketBeat’s stock screener tool. Healthcare stocks are shares in companies that operate within the health sector, including businesses involved in pharmaceuticals, biotechnology, medical equipment, and healthcare services. These stocks offer investors exposure to the dynamic healthcare industry, which often benefits from technological advancements, an aging population, and increasing global demand for improved medical care. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of MRK traded down $1.29 during midday trading on Friday, reaching $93.44. 68,284,470 shares of the stock were exchanged, compared to its average volume of 10,227,995. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of 0.79. The stock’s 50 day simple moving average is $93.00 and its 200 day simple moving average is $101.07. Merck & Co., Inc. has a twelve month low of $81.04 and a twelve month high of $134.63. The company has a market cap of $236.03 billion, a P/E ratio of 13.88, a PEG ratio of 0.77 and a beta of 0.35.

Alphabet (GOOGL)

Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube.

Shares of GOOGL stock traded up $1.19 during trading on Friday, hitting $163.99. The company had a trading volume of 36,577,258 shares, compared to its average volume of 25,871,209. The firm has a market capitalization of $2.00 trillion, a P/E ratio of 20.37, a price-to-earnings-growth ratio of 1.34 and a beta of 1.02. Alphabet has a one year low of $147.22 and a one year high of $207.05. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.84 and a current ratio of 1.84. The stock’s 50-day moving average price is $182.57 and its 200 day moving average price is $176.51.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of NYSE:UNH traded up $6.42 during trading on Friday, reaching $517.72. 10,192,902 shares of the company traded hands, compared to its average volume of 4,088,232. The firm has a market capitalization of $473.57 billion, a PE ratio of 33.40, a PEG ratio of 1.37 and a beta of 0.62. The company’s 50 day moving average is $510.19 and its two-hundred day moving average is $547.11. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

Amgen (AMGN)

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout.

Amgen stock traded up $1.00 during trading hours on Friday, reaching $316.04. 9,994,350 shares of the stock were exchanged, compared to its average volume of 2,553,454. The company has a current ratio of 1.26, a quick ratio of 0.95 and a debt-to-equity ratio of 9.62. Amgen has a twelve month low of $253.30 and a twelve month high of $346.85. The company has a market cap of $169.78 billion, a P/E ratio of 41.86, a price-to-earnings-growth ratio of 2.63 and a beta of 0.53. The stock has a 50 day moving average of $297.24 and a two-hundred day moving average of $298.80.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of Johnson & Johnson stock traded up $0.38 on Friday, reaching $163.40. 17,012,477 shares of the stock were exchanged, compared to its average volume of 7,088,732. The firm’s 50 day moving average is $156.99 and its 200-day moving average is $156.25. The firm has a market cap of $393.76 billion, a PE ratio of 24.57, a P/E/G ratio of 2.56 and a beta of 0.47. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.86 and a current ratio of 1.11. Johnson & Johnson has a one year low of $140.68 and a one year high of $169.99.

Salesforce (CRM)

Salesforce, Inc. provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide. The company's service includes sales to store data, monitor leads and progress, forecast opportunities, gain insights through analytics and artificial intelligence, and deliver quotes, contracts, and invoices; and service that enables companies to deliver trusted and highly personalized customer support at scale.

NYSE CRM traded up $2.53 on Friday, hitting $281.56. 9,798,917 shares of the company’s stock were exchanged, compared to its average volume of 6,385,139. Salesforce has a 52 week low of $212.00 and a 52 week high of $369.00. The stock has a 50-day moving average of $313.51 and a 200-day moving average of $309.92. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.14. The stock has a market cap of $270.58 billion, a price-to-earnings ratio of 46.31, a P/E/G ratio of 2.58 and a beta of 1.35.

Oracle (ORCL)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Shares of Oracle stock traded up $0.11 during trading on Friday, reaching $152.83. 17,559,020 shares of the company’s stock were exchanged, compared to its average volume of 8,515,324. The firm’s 50-day moving average price is $164.87 and its 200 day moving average price is $170.06. The company has a market cap of $427.45 billion, a P/E ratio of 37.37, a PEG ratio of 3.46 and a beta of 1.07. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. Oracle has a 1-year low of $112.78 and a 1-year high of $198.31.